Mingyue Zhu

Key Laboratory Of Tropical Translational Medicine, Ministry Of Education And Hainan Provincial Key Laboratory Of Carcinogenesis And Intervention
Haikou, 571199, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 61 publications

AFP confers the resistance of lenvatinib in hepatocellular carcinoma by activating PI3K/AKT/LDHA signaling axis.

AFP confers the resistance of lenvatinib in hepatocellular carcinoma by activating PI3K/AKT/LDHA signaling axis.

Journal: Discover oncology

Published: December 15, 2025

Lactylation modification of tumor suppressor proteins promotes immune tolerance in hepatocellular carcinoma.

Lactylation modification of tumor suppressor proteins promotes immune tolerance in hepatocellular carcinoma.

Journal: Chinese medical journal

Published: December 05, 2025

Protein expression profiling of lenvatinib-resistant liver cancer cells and identify B4GALT4 as a critical drug resistance molecule.

Protein expression profiling of lenvatinib-resistant liver cancer cells and identify B4GALT4 as a critical drug resistance molecule.

Journal: Discover oncology

Published: November 12, 2025

HBx Promotes Liver Cancer Cells to Escape NK-92 Cell Attack by Mediating ADAM10 to Enzyme Cut MICA/B Shedding From Cancer Cell Membrane.

HBx Promotes Liver Cancer Cells to Escape NK-92 Cell Attack by Mediating ADAM10 to Enzyme Cut MICA/B Shedding From Cancer Cell Membrane.

Journal: Journal of cellular and molecular medicine

Published: July 29, 2025

AFP Stimulates Glucose Metabolic Reprogramming Contributing to Hepatocellular Carcinoma Resist Sorafenib Through Activating PI3K/AKT Signalling Pathway.

AFP Stimulates Glucose Metabolic Reprogramming Contributing to Hepatocellular Carcinoma Resist Sorafenib Through Activating PI3K/AKT Signalling Pathway.

Journal: Journal of cellular and molecular medicine

Published: July 05, 2025

AFP promotes cancer multidrug resistance through activating PI3K/Akt/NF-κB signaling pathway.

AFP promotes cancer multidrug resistance through activating PI3K/Akt/NF-κB signaling pathway.

Journal: Scientific reports

Published: June 12, 2025

HBx Drives Liver Cancer Stem Cell Generation Through Stimulating Glucose Metabolic Reprogramming.

HBx Drives Liver Cancer Stem Cell Generation Through Stimulating Glucose Metabolic Reprogramming.

Journal: Journal of cellular and molecular medicine

Published: April 22, 2025

CD47-SIRPα: A Pivotal Signaling Pathway for Targeting Immunotherapy in Non-Small Cell Lung Cancer.

CD47-SIRPα: A Pivotal Signaling Pathway for Targeting Immunotherapy in Non-Small Cell Lung Cancer.

Journal: Current medicinal chemistry

Published: February 10, 2025

USP39 promote post-translational modifiers to stimulate the progress of cancer.

USP39 promote post-translational modifiers to stimulate the progress of cancer.

Journal: Discover oncology

Published: January 05, 2025

Alpha-Fetoprotein Stimulates Cleavage of Membranal MICA/B on Liver Cancer Cell Lead to Escape Immune Surveillance of Natural Killer Cells.

Alpha-Fetoprotein Stimulates Cleavage of Membranal MICA/B on Liver Cancer Cell Lead to Escape Immune Surveillance of Natural Killer Cells.

Journal: Journal of cellular and molecular medicine

Published: November 05, 2024

Spatial heterogeneity of the hepatocellular carcinoma microenvironment determines the efficacy of immunotherapy.

Spatial heterogeneity of the hepatocellular carcinoma microenvironment determines the efficacy of immunotherapy.

Journal: Discover oncology

Published: September 01, 2024

AFP shields hepatocellular carcinoma from macrophage phagocytosis by regulating HuR-mediated CD47 translocation in cellular membrane.

AFP shields hepatocellular carcinoma from macrophage phagocytosis by regulating HuR-mediated CD47 translocation in cellular membrane.

Journal: Translational oncology

Published: May 23, 2024

Showing 1-12 of 61

Last Updated: 09/26/2026